Testosterone Gel Stops Dangerous Belly Fat Gain in Older Women After Hip Fracture
A clinical trial found testosterone gel plus exercise prevented visceral fat increases in women over 65 recovering from hip fractures.
Summary
As we age, fat migrates from harmless subcutaneous layers into dangerous visceral deposits around internal organs, raising risks for diabetes and heart disease. A University of Connecticut study tested whether a topical testosterone gel combined with exercise could counter this shift in older women recovering from hip fractures. In a 66-person trial, women using the gel maintained stable visceral fat levels over six months, while those without the hormone saw visceral fat increase — the typical post-injury pattern. Total body fat was similar between groups, meaning the testosterone selectively targeted the dangerous fat compartment. This finding challenges blanket weight-loss strategies that also strip away muscle, and points toward hormone-assisted recovery as a smarter approach to body composition management in aging adults.
Detailed Summary
Visceral fat — the deep abdominal fat surrounding internal organs — is one of the most dangerous forms of fat accumulation linked to diabetes, cardiovascular disease, and metabolic dysfunction. Unlike subcutaneous fat just beneath the skin, visceral fat is metabolically active in harmful ways, and it tends to increase with age and after physical injury or immobility.
Researchers at the University of Connecticut, led by kinesiology professor Jacob Earp, investigated whether topical testosterone gel could prevent this dangerous fat redistribution in older women recovering from hip fractures. Hip fractures affect women nearly three times more often than men and are a leading cause of lost independence in older adults. Recovery periods typically accelerate visceral fat accumulation due to reduced mobility.
The randomized clinical trial enrolled 66 women over age 65 recovering from recent hip fractures. All participants completed a structured exercise program, but only one group also applied a testosterone gel. DXA body composition scans were taken at baseline and again after six months. The results, published in Obesity Pillars, showed no significant difference in total body fat between groups — but a striking difference in where fat was stored. Women using testosterone maintained or reduced visceral fat, while the control group experienced the expected visceral fat increase.
This selective effect on fat distribution is clinically significant. Standard weight-loss interventions reduce overall mass, including muscle — a serious concern for aging adults where muscle preservation is critical for mobility, fall prevention, and metabolic health. Testosterone therapy appears to target the visceral compartment specifically, offering a more precise tool for body composition management.
Caveats remain. The study focused exclusively on older women post-fracture, so generalizability to other populations is unclear. Testosterone therapy carries known risks including cardiovascular effects and hormonal side effects that require careful clinical oversight. Larger and longer trials are needed before this becomes a standard recommendation.
Key Findings
- Testosterone gel prevented visceral fat increases in women over 65 recovering from hip fractures over 6 months.
- Total body fat was unchanged between groups, confirming testosterone selectively targeted dangerous visceral fat.
- Control group showed expected visceral fat rise post-fracture; testosterone group bucked this trend entirely.
- Combining hormone therapy with structured exercise may offer a targeted alternative to blanket weight-loss strategies.
- Visceral fat accumulation after injury is a modifiable risk factor, not an inevitable consequence of aging.
Methodology
This is a research summary based on a published clinical trial from the University of Connecticut, appearing in Obesity Pillars, a peer-reviewed journal. The study used a controlled design with 66 participants, DXA imaging for body composition, and a six-month follow-up period, lending reasonable credibility. The source article is a news report summarizing the primary research rather than the full study itself.
Study Limitations
The study population was limited to women over 65 recovering from hip fractures, limiting generalizability to broader aging populations or men. Long-term safety data on testosterone gel use in older women — including cardiovascular and hormonal risks — is not addressed in this summary. Readers should consult the primary Obesity Pillars publication for full methodology, dosing details, and adverse event reporting.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.